as on March 2, 2026 at 9:31 pm IST
Day's Low
Day's High
1.39%
Downside
3.87%
Upside
52 Week's Low
52 Week's High
44.01%
Downside
11.62%
Upside
as on March 2, 2026 at 4:01 pm IST
Market Cap
₹177.00 Cr
Return on Equity (ROE)
4.33
PE Ratio (TTM)
102.9
Return on capital employed (ROCE)
3.79
Industry PE ratio
42.16
Beta (LTM)
0.92
P/B Ratio
3.34
Dividend Yield
0PEG Ratio
37.28
Quarterly Earnings Growth YOY
100
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Neutral
View Technical Analysis
as on March 2, 2026 at 4:01 pm IST
Auro Laboratories in the last 5 years
Lowest (0.00x)
September 29, 2025
Industry (42.16x)
March 2, 2026
Today (102.90x)
March 2, 2026
Highest (109.44x)
February 18, 2026
Today’s Price to Earnings Ratio: 102.90x
Compare market cap, revenue, PE, and other key metrics of Auro Laboratories with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 177.00 | 44.18% | 0.00 | 1 | 19 | |
| NA | 2,693.53 | 8.95% | 0.68 | 3 | 2,711 | |
| NA | 19.31 | -8.72% | 0.00 | 2 | 33 | |
| NA | 104.23 | -16.96% | 0.59 | 25 | 292 | |
| BUY | 3,527.70 | 7.5% | 0.65 | 58 | 398 |
Search interest for Auro Laboratories Ltd Stock has increased by 27% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:27% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Auro Laboratories.
Auro Laboratories Ltd’s net profit jumped 100% since last year same period to ₹0.72Cr in the Q2 2025-2026. On a quarterly growth basis, Auro Laboratories Ltd has generated 754.55% jump in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
![]()
In the last 3 years, Auro Labs. has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Price Rise
![]()
In the last 1 month, Auro Labs. stock has moved up by 15.5%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 52.18% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 47.7% return, outperforming this stock by 16.2%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 47.82% of holdings in Dec 2025 quarter
| Organisation | Auro Laboratories Ltd |
| Industry | Pharmaceuticals |
| CEO | Sharat Deorah |
| E-voting on shares | Click here to vote |
Auro Laboratories share price today stands at ₹284 as on at the close of the market. Auro Laboratories share today touched a day high of ₹295 and a low of ₹280.05.
Auro Laboratories touched a 52 week high of ₹317 and a 52 week low of ₹159. Auro Laboratories share price today i.e. is closed at ₹284, which is -10.41% down from its 52 week high and 78.62% up from its 52 week low.
Auro Laboratories market capitalisation is ₹177.00 Cr as on .
To buy Auro Laboratories shares, you need to follow these steps:
Auro Laboratories trading volume is 2,902.00 as on . This means that 2,902.00 shares of Auro Laboratories were bought and sold on the stock market during today's trading session.